Studies from McMaster University Provide New Data on Ischemia [Factor Xia Inhibition With Asundexian After Acute Non-cardioembolic Ischaemic Stroke (Pacific-stroke): an International, Randomised, Double-blind, Placebo- Controlled, Phase 2b Trial]

Source :: Health & Medicine Week. November 25, 2022, 5492
Publication Year :: 2022
Abstract: 2022 NOV 25 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Fresh data on Vascular Diseases and Conditions - Ischemia are presented in a [...]

Subjects :: Bayer AG -- Product development
Stroke (Disease) -- Research
Ischemia -- Research
Clinical trials -- Research
Pharmaceutical industry -- Product development
Health
McMaster University

Tools